Tangbikang Granules Modulates AMPK/NF-κB Pathway to Alleviate Sciatic Nerve Inflammation in Diabetic Rats
10.13422/j.cnki.syfjx.20230723
- VernacularTitle:糖痹康颗粒调控AMPK/NF-κB通路改善糖尿病大鼠坐骨神经炎症反应
- Author:
Huizhong BAI
1
;
Lingling QIN
2
;
Yaqi ZHANG
1
;
Chengfei ZHANG
3
;
Qiue ZHANG
4
;
Xinwei ZUO
1
;
Gang LIU
1
;
Yu ZHAO
1
;
Yi ZHAO
1
;
Tonghua LIU
5
;
Xiaohong MU
1
Author Information
1. Dongzhimen Hospital， Beijing University of Chinese Medicine， Beijing 100700， China
2. Science and Technology Office， Beijing University of Chinese Medicine， Beijing 100029， China
3. School of Life Sciences， Beijing University of Chinese Medicine， Beijing 100029， China
4. School of Traditional Chinese Medicine （TCM）， Beijing University of Chinese Medicine， Beijing 100029， China
5. Beijing Key Laboratory of TCM Health Sciences， Beijing University of Chinese Medicine， Beijing 100029， China
- Publication Type:Journal Article
- Keywords:
Tangbikang granules;
nuclear factor-κB （NF-κB）;
adenosine monophosphate-activated protein kinase （AMPK）;
diabetic peripheral neuropathy;
animal experiments;
nerveinflammation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(9):91-98
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the effect of Tangbikang granules （TBK） on sciatic nerve inflammation in diabetic rats through modulation of adenosine monophosphate-activated protein kinase （AMPK）/nuclear factor （NF）-κB pathway. MethodSD rats were fed with high-fat and high-sugar diet for 8 weeks and then treated with streptozotocin （STZ， ip） at 35 mg·kg-1 for modeling. Then the rats were randomized into diabetes group， low-dose （0.625 g·kg-1）， medium-dose （1.25 g·kg-1）， and high-dose （2.5 g·kg-1） TBK groups， and lipoic acid group （0.026 8 g·kg-1） according to body weight and blood glucose level， and a normal group was designed. After modeling， administration began and lasted 12 weeks. The body mass， blood glucose level， and thermal withdrawal latency （TWL） of the rats were detected before treatment and at the 4th， 8th， and 12th week of administration. At the 12th week， the sciatic nerve was collected for hematoxylin-eosin （HE） and Luxol fast blue （LFB） staining， and the structural changes of sciatic nerve were observed under scanning electron microscope. The levels of interleukin-1β （IL-1β） and tumor necrosis factor-α （TNF-α） in sciatic nerve were measured by enzyme-linked immunosorbent assay （ELISA）， and the levels of AMPK， phosphorylated （p）-AMPK， and NF-κB proteins in the sciatic nerve were measured by Western blot. ResultThe blood glucose concentration and TWL in the model group were higher than those in the normal group at each time point （P<0.01）. The levels of IL-1β， TNF-α， and NF-κB protein in sciatic nerve in the model group were higher than those in the normal group （P<0.01）， and the p-AMPK/AMPK ratio was smaller than that in the normal group （P<0.01）. Compared with the model group， TBK of the three doses lowered the TWL （P<0.05， P<0.01） and the levels of IL-1β， TNF-α， and NF-κB protein in sciatic nerve of rats （P<0.05， P<0.01）， and high-dose and medium-dose TBK raised p-AMPK/AMPK （P<0.05， P<0.01）. The sciatic nerve fibers were orderly and compact with alleviation of demyelination in rats treated with TBK compared with those in the model group. ConclusionTBK improves the function of sciatic nerve and alleviates neuroinflammation in diabetic rats. The mechanism is the likelihood that it up-regulates the expression of AMPK in the AMPK/NF-κB pathway and inhibits the expression of downstream NF-κB， thereby alleviating the neuroinflammation caused by high levels of inflammatory factors such as IL-1β and TNF-α due to NF-κB activation.
